In contrast, Syk serves as a tumour promoter in hematopoietic malignancies and could be a potential oncogenic driver in small cell lung cancer [37] and ovarian cancer [36] by inducing pro-survival signals [13]. The gene discussed is SYK; the disease is ovarian carcinoma.